Ranking · Summer 2021 · Healthcare · Diagnostics

AOA Dx

Blood Test for Early Detection of Ovarian Cancer

5.9%

odds of being acquired in the next two years

0.9× the average (6.8%)

#2798 of 4,339 active YC companies · top 65%

Team of 25 · Denver, CO, USA; Cambridge, MA, USA

Raises the odds

↑ based in United States of America

↑ based in America / Canada

↑ changed its name (pivot)

↑ based in Remote

Lowers the odds

↓ industry: Healthcare

↓ tag: Healthcare

↓ sector: Diagnostics

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads AOA Dx's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

aoadx.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub